Ovarian cancer has historically been called a “ silent killer ,” because clinicians thought its symptoms were undetectable. Patients were often diagnosed so late that doctors thought nothing could be ...

The comparable rates of remission pre- and post-pandemic suggest that COVID-19 did not negatively impact the outcomes of ...

The World Ovarian Cancer Coalition (the Coalition) announced today the publication of a first-of-its-kind study that reveals ...

LIKE many cancers, ovarian cancer has long been known as a ‘silent’ disease. This is because its symptoms tend to be vague, ...

Clinical trials of a simple and accurate blood test to detect early-stage ovarian cancer – key to boosting survival rates – ...

Clinical trials of a simple and accurate blood test to detect early-stage ovarian cancer - key to boosting survival rates - ...

Ovarian cancer is one of the deadliest gynaecological cancers, yet there currently is no early diagnostic test. Here’s what you need to know.

Queensland women are to take part in groundbreaking clinical trials for a blood test that will detect early stage ovarian cancer.

Discover a study that describes a host-intrinsic mechanism responsible for the failure of PD-L1 blockade in ovarian cancer.

Results from OVATION 2 Study continue to validate TheraPlas® technology, demonstrating DNA-mediated production of key anti-cancer immune cytokines following treatment IMNN-001 continues to show ...